发明名称 PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S
摘要 <p>The invention provides compounds of the formula (I), or salts, tautomers, N-oxides or solvates thereof wherein: R1 is selected from: (a) 2,6-dichlorophenyl; (b) 2,6-difluorophenyl; (c) a 2,3,6-trisubstituted phenyl group wherein the substituents for the phenyl group are selected from fluorine, chlorine, methyl and methoxy; (d) a group R0; (e) a group R a; (f) a group Rlb; (g) a group Rlc; (h) a group Rld; and 0) 2,6-difluorophenylamino ; wherein R )0?, r R&gt; llaa, T Rj I1bD, T R) I1cC, r R&gt; Iida, r R»2zaa, r R&gt;22bD and RJ are as defined in the claims. The compounds have activity as inhibitors of cdk kinase (such as cdkl or cdk2) and glycogen synthase kinase-3 activity.</p>
申请公布号 WO2006077414(A1) 申请公布日期 2006.07.27
申请号 WO2006GB00191 申请日期 2006.01.20
申请人 ASTEX THERAPEUTICS LIMITED;WYATT, PAUL, GRAHAM;BERDINI, VALERIO;GILL, ADRIAN, LIAM;TREWARTHA, GARY;WOODHEAD, ANDREW, JAMES;NAVARRO, EVA, FIGUEROA;O'BRIEN, MICHAEL, ALISTAIR;PHILLIPS, THERESA, RACHEL 发明人 WYATT, PAUL, GRAHAM;BERDINI, VALERIO;GILL, ADRIAN, LIAM;TREWARTHA, GARY;WOODHEAD, ANDREW, JAMES;NAVARRO, EVA, FIGUEROA;O'BRIEN, MICHAEL, ALISTAIR;PHILLIPS, THERESA, RACHEL
分类号 C07D401/14;A01N43/56;A61K31/44;A61P35/00 主分类号 C07D401/14
代理机构 代理人
主权项
地址